Matrix metalloproteinases and their tissue inhibitors genes abnormal DNA methylation in breast cancer

被引：0

作者：

Simonova, O. ^{[1
]}

Kuznetsova, E. ^{[2
]}

Tanas, A. S. ^{[1
]}

Rudenko, V. ^{[1
]}

Poddubskaya, E. ^{[3
]}

Kekeeva, T. ^{[1
]}

Chesnokova, G. ^{[1
]}

Kutsev, S. ^{[1
]}

Zaletaev, D. V. ^{[2
]}

Nemtsova, M. V. ^{[2
]}

Strelnikov, V. V. ^{[1
]}

机构：

[1] Fed State Budgetary Sci Inst, Epigenet, Res Ctr Med Genet, Moscow, Russia

[2] IM Sechenov First Moscow State Med Univ, Genet Lab, Moscow, Russia

[3] IM Sechenov First Moscow State Med Univ, Inst Personalized Med, Moscow, Russia

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

20P

引用

页数：1

共 50 条

[11] Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer
Ki-Nam Shim
Sung-Ae Jung
Yang-Hee Joo
Kwon Yoo
Journal of Gastroenterology, 2007, 42 : 120 - 128
[12] Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging
Baker, EA
Bergin, FG
Leaper, DJ
BRITISH JOURNAL OF SURGERY, 2000, 87 (09) : 1215 - 1221
[13] Tissue inhibitors of matrix metalloproteinases as cytostatic agents in cancer
Imren, S
Kohn, DB
Declerck, YA
TISSUE INHIBITORS OF METALLOPROTEINASES IN DEVELOPMENT AND DISEASE, PROCEEDINGS, 2000, : 153 - 158
[14] Matrix metalloproteinases and their tissue inhibitors
Timms, PM
Campbell, S
Srikanthan, V
Price, CP
BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH, 2002, : 379 - 388
[15] EXPRESSION OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS IN HUMAN BREAST CARCINOMAS
POLETTE, M
NOEL, A
NAWROCKI, B
FOIDART, JM
BIREMBAUT, P
CELL BIOLOGY INTERNATIONAL, 1995, 19 (03) : 243 - 244
[16] Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer
Jobim, F. C.
Xavier, N. L.
Uchoa, D. M.
Cruz, D. B.
Saciloto, M.
Chemello, N.
Schwartsmann, G.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (10) : 979 - 987
[17] Breast cancer epigenetics: abnormal promoter methylation of matrix and transmembrane proteins encoding genes
Simonova, O. A.
Kuznetsova, E. B.
Rudenco, V. V.
Poddubskaya, E. V.
Kerimov, R. A.
Tanas, A. S.
Strelnikov, V. V.
Zaletaev, D. V.
EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 604 - 605
[18] Metalloproteinases and tissue inhibitors of matrix-metalloproteinases in plasma of patients with prostate cancer and in prostate cancer tissue
Lein, M
Nowak, L
Jung, K
Laube, C
Ulbricht, N
Schnorr, D
Loening, SA
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 544 - 546
[19] Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases
Borden, P
Heller, RA
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1997, 7 (1-2): : 159 - 178
[20] Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease
Zakiyanov, Oskar
Kalousova, Marta
Zima, Tomas
Tesar, Vladimir
ADVANCES IN CLINICAL CHEMISTRY, VOL 105, 2021, 105 : 141 - 212

← 1 2 3 4 5 →